nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—Sulfasalazine—ankylosing spondylitis	0.633	1	CrCtD
Vismodegib—Sulfapyridine—Sulfasalazine—ankylosing spondylitis	0.188	1	CrCrCtD
Vismodegib—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0258	0.151	CbGbCtD
Vismodegib—ALB—Prednisone—ankylosing spondylitis	0.0142	0.0833	CbGbCtD
Vismodegib—ABCG2—Dexamethasone—ankylosing spondylitis	0.0129	0.0755	CbGbCtD
Vismodegib—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0123	0.0719	CbGbCtD
Vismodegib—ABCG2—Methotrexate—ankylosing spondylitis	0.0103	0.0607	CbGbCtD
Vismodegib—CYP2C19—Prednisone—ankylosing spondylitis	0.0092	0.054	CbGbCtD
Vismodegib—ABCB1—Betamethasone—ankylosing spondylitis	0.00797	0.0468	CbGbCtD
Vismodegib—ABCB1—Prednisolone—ankylosing spondylitis	0.00786	0.0462	CbGbCtD
Vismodegib—ABCB1—Prednisone—ankylosing spondylitis	0.00742	0.0436	CbGbCtD
Vismodegib—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00734	0.0431	CbGbCtD
Vismodegib—ALB—Methotrexate—ankylosing spondylitis	0.00712	0.0418	CbGbCtD
Vismodegib—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00685	0.0402	CbGbCtD
Vismodegib—CYP2C19—Dexamethasone—ankylosing spondylitis	0.00574	0.0337	CbGbCtD
Vismodegib—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00556	0.0327	CbGbCtD
Vismodegib—SHH—vertebral column—ankylosing spondylitis	0.00482	0.711	CbGeAlD
Vismodegib—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00478	0.028	CbGbCtD
Vismodegib—CYP3A4—Betamethasone—ankylosing spondylitis	0.00477	0.028	CbGbCtD
Vismodegib—CYP3A4—Prednisolone—ankylosing spondylitis	0.00471	0.0277	CbGbCtD
Vismodegib—ABCB1—Dexamethasone—ankylosing spondylitis	0.00464	0.0272	CbGbCtD
Vismodegib—CYP3A4—Prednisone—ankylosing spondylitis	0.00445	0.0261	CbGbCtD
Vismodegib—ABCB1—Methotrexate—ankylosing spondylitis	0.00372	0.0219	CbGbCtD
Vismodegib—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00278	0.0163	CbGbCtD
Vismodegib—ORM1—vertebral column—ankylosing spondylitis	0.00147	0.217	CbGeAlD
Vismodegib—SMO—tendon—ankylosing spondylitis	0.000488	0.0719	CbGeAlD
Vismodegib—Blood potassium decreased—Methylprednisolone—ankylosing spondylitis	9.66e-05	0.0562	CcSEcCtD
Vismodegib—Blood potassium decreased—Prednisone—ankylosing spondylitis	7.65e-05	0.0445	CcSEcCtD
Vismodegib—Azotaemia—Methotrexate—ankylosing spondylitis	4.56e-05	0.0265	CcSEcCtD
Vismodegib—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	4.18e-05	0.0243	CcSEcCtD
Vismodegib—Amenorrhoea—Betamethasone—ankylosing spondylitis	3.8e-05	0.0221	CcSEcCtD
Vismodegib—Amenorrhoea—Dexamethasone—ankylosing spondylitis	3.8e-05	0.0221	CcSEcCtD
Vismodegib—Amenorrhoea—Prednisone—ankylosing spondylitis	3.31e-05	0.0192	CcSEcCtD
Vismodegib—Blood alkaline phosphatase increased—Methylprednisolone—ankylosing spondylitis	3.06e-05	0.0178	CcSEcCtD
Vismodegib—Hepatic enzyme increased—Methotrexate—ankylosing spondylitis	2.57e-05	0.0149	CcSEcCtD
Vismodegib—Breast disorder—Methylprednisolone—ankylosing spondylitis	2.41e-05	0.014	CcSEcCtD
Vismodegib—Hypokalaemia—Dexamethasone—ankylosing spondylitis	2.21e-05	0.0128	CcSEcCtD
Vismodegib—Hypokalaemia—Betamethasone—ankylosing spondylitis	2.21e-05	0.0128	CcSEcCtD
Vismodegib—Hypokalaemia—Prednisone—ankylosing spondylitis	1.92e-05	0.0112	CcSEcCtD
Vismodegib—Weight decreased—Betamethasone—ankylosing spondylitis	1.89e-05	0.011	CcSEcCtD
Vismodegib—Weight decreased—Dexamethasone—ankylosing spondylitis	1.89e-05	0.011	CcSEcCtD
Vismodegib—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	1.81e-05	0.0105	CcSEcCtD
Vismodegib—Weight decreased—Prednisone—ankylosing spondylitis	1.65e-05	0.0096	CcSEcCtD
Vismodegib—Malnutrition—Methylprednisolone—ankylosing spondylitis	1.6e-05	0.00933	CcSEcCtD
Vismodegib—Breast disorder—Methotrexate—ankylosing spondylitis	1.59e-05	0.00927	CcSEcCtD
Vismodegib—Dysgeusia—Triamcinolone—ankylosing spondylitis	1.57e-05	0.00916	CcSEcCtD
Vismodegib—Back pain—Triamcinolone—ankylosing spondylitis	1.56e-05	0.00905	CcSEcCtD
Vismodegib—Alopecia—Dexamethasone—ankylosing spondylitis	1.48e-05	0.00862	CcSEcCtD
Vismodegib—Alopecia—Betamethasone—ankylosing spondylitis	1.48e-05	0.00862	CcSEcCtD
Vismodegib—Connective tissue disorder—Prednisone—ankylosing spondylitis	1.43e-05	0.00834	CcSEcCtD
Vismodegib—Myalgia—Triamcinolone—ankylosing spondylitis	1.37e-05	0.00796	CcSEcCtD
Vismodegib—Arthralgia—Methylprednisolone—ankylosing spondylitis	1.37e-05	0.00795	CcSEcCtD
Vismodegib—Myalgia—Methylprednisolone—ankylosing spondylitis	1.37e-05	0.00795	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	1.36e-05	0.00789	CcSEcCtD
Vismodegib—Alopecia—Prednisone—ankylosing spondylitis	1.29e-05	0.0075	CcSEcCtD
Vismodegib—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	1.28e-05	0.00747	CcSEcCtD
Vismodegib—Skin disorder—Methylprednisolone—ankylosing spondylitis	1.27e-05	0.0074	CcSEcCtD
Vismodegib—Malnutrition—Prednisone—ankylosing spondylitis	1.27e-05	0.00739	CcSEcCtD
Vismodegib—Myalgia—Betamethasone—ankylosing spondylitis	1.24e-05	0.00723	CcSEcCtD
Vismodegib—Myalgia—Dexamethasone—ankylosing spondylitis	1.24e-05	0.00723	CcSEcCtD
Vismodegib—Pain—Prednisolone—ankylosing spondylitis	1.22e-05	0.0071	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	1.2e-05	0.00696	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	1.19e-05	0.00694	CcSEcCtD
Vismodegib—Nervous system disorder—Dexamethasone—ankylosing spondylitis	1.17e-05	0.00679	CcSEcCtD
Vismodegib—Nervous system disorder—Betamethasone—ankylosing spondylitis	1.17e-05	0.00679	CcSEcCtD
Vismodegib—Dyspepsia—Triamcinolone—ankylosing spondylitis	1.16e-05	0.00672	CcSEcCtD
Vismodegib—Dyspepsia—Methylprednisolone—ankylosing spondylitis	1.15e-05	0.00671	CcSEcCtD
Vismodegib—Fatigue—Triamcinolone—ankylosing spondylitis	1.13e-05	0.00658	CcSEcCtD
Vismodegib—Fatigue—Methylprednisolone—ankylosing spondylitis	1.13e-05	0.00657	CcSEcCtD
Vismodegib—Pain—Triamcinolone—ankylosing spondylitis	1.12e-05	0.00653	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	1.08e-05	0.00631	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	1.08e-05	0.00631	CcSEcCtD
Vismodegib—Myalgia—Prednisone—ankylosing spondylitis	1.08e-05	0.00629	CcSEcCtD
Vismodegib—Arthralgia—Prednisone—ankylosing spondylitis	1.08e-05	0.00629	CcSEcCtD
Vismodegib—Alopecia—Methotrexate—ankylosing spondylitis	1.08e-05	0.00627	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	1.07e-05	0.00625	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	1.07e-05	0.00623	CcSEcCtD
Vismodegib—Malnutrition—Methotrexate—ankylosing spondylitis	1.06e-05	0.00618	CcSEcCtD
Vismodegib—Dyspepsia—Dexamethasone—ankylosing spondylitis	1.05e-05	0.0061	CcSEcCtD
Vismodegib—Dyspepsia—Betamethasone—ankylosing spondylitis	1.05e-05	0.0061	CcSEcCtD
Vismodegib—Dysgeusia—Methotrexate—ankylosing spondylitis	1.04e-05	0.00605	CcSEcCtD
Vismodegib—Abdominal pain—Methylprednisolone—ankylosing spondylitis	1.04e-05	0.00602	CcSEcCtD
Vismodegib—Decreased appetite—Betamethasone—ankylosing spondylitis	1.04e-05	0.00602	CcSEcCtD
Vismodegib—Decreased appetite—Dexamethasone—ankylosing spondylitis	1.04e-05	0.00602	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	1.03e-05	0.00598	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	1.03e-05	0.00598	CcSEcCtD
Vismodegib—Back pain—Methotrexate—ankylosing spondylitis	1.03e-05	0.00598	CcSEcCtD
Vismodegib—Fatigue—Dexamethasone—ankylosing spondylitis	1.03e-05	0.00597	CcSEcCtD
Vismodegib—Fatigue—Betamethasone—ankylosing spondylitis	1.03e-05	0.00597	CcSEcCtD
Vismodegib—Pain—Betamethasone—ankylosing spondylitis	1.02e-05	0.00592	CcSEcCtD
Vismodegib—Pain—Dexamethasone—ankylosing spondylitis	1.02e-05	0.00592	CcSEcCtD
Vismodegib—Nervous system disorder—Prednisone—ankylosing spondylitis	1.02e-05	0.00592	CcSEcCtD
Vismodegib—Skin disorder—Prednisone—ankylosing spondylitis	1.01e-05	0.00586	CcSEcCtD
Vismodegib—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	9.74e-06	0.00566	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	9.74e-06	0.00566	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	9.45e-06	0.0055	CcSEcCtD
Vismodegib—Asthenia—Triamcinolone—ankylosing spondylitis	9.42e-06	0.00548	CcSEcCtD
Vismodegib—Abdominal pain—Dexamethasone—ankylosing spondylitis	9.41e-06	0.00548	CcSEcCtD
Vismodegib—Abdominal pain—Betamethasone—ankylosing spondylitis	9.41e-06	0.00548	CcSEcCtD
Vismodegib—Asthenia—Methylprednisolone—ankylosing spondylitis	9.4e-06	0.00547	CcSEcCtD
Vismodegib—Pruritus—Triamcinolone—ankylosing spondylitis	9.29e-06	0.0054	CcSEcCtD
Vismodegib—Pruritus—Methylprednisolone—ankylosing spondylitis	9.26e-06	0.00539	CcSEcCtD
Vismodegib—Dyspepsia—Prednisone—ankylosing spondylitis	9.13e-06	0.00531	CcSEcCtD
Vismodegib—Myalgia—Methotrexate—ankylosing spondylitis	9.04e-06	0.00526	CcSEcCtD
Vismodegib—Arthralgia—Methotrexate—ankylosing spondylitis	9.04e-06	0.00526	CcSEcCtD
Vismodegib—Decreased appetite—Prednisone—ankylosing spondylitis	9.01e-06	0.00524	CcSEcCtD
Vismodegib—Rash—Prednisolone—ankylosing spondylitis	9e-06	0.00523	CcSEcCtD
Vismodegib—Dermatitis—Prednisolone—ankylosing spondylitis	8.99e-06	0.00523	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	8.98e-06	0.00522	CcSEcCtD
Vismodegib—Diarrhoea—Methylprednisolone—ankylosing spondylitis	8.96e-06	0.00521	CcSEcCtD
Vismodegib—Fatigue—Prednisone—ankylosing spondylitis	8.94e-06	0.0052	CcSEcCtD
Vismodegib—Constipation—Prednisone—ankylosing spondylitis	8.87e-06	0.00516	CcSEcCtD
Vismodegib—Asthenia—Dexamethasone—ankylosing spondylitis	8.54e-06	0.00497	CcSEcCtD
Vismodegib—Asthenia—Betamethasone—ankylosing spondylitis	8.54e-06	0.00497	CcSEcCtD
Vismodegib—Nervous system disorder—Methotrexate—ankylosing spondylitis	8.5e-06	0.00494	CcSEcCtD
Vismodegib—Gastrointestinal pain—Prednisone—ankylosing spondylitis	8.48e-06	0.00493	CcSEcCtD
Vismodegib—Nausea—Prednisolone—ankylosing spondylitis	8.48e-06	0.00493	CcSEcCtD
Vismodegib—Pruritus—Betamethasone—ankylosing spondylitis	8.43e-06	0.0049	CcSEcCtD
Vismodegib—Pruritus—Dexamethasone—ankylosing spondylitis	8.43e-06	0.0049	CcSEcCtD
Vismodegib—Skin disorder—Methotrexate—ankylosing spondylitis	8.42e-06	0.0049	CcSEcCtD
Vismodegib—Vomiting—Triamcinolone—ankylosing spondylitis	8.34e-06	0.00485	CcSEcCtD
Vismodegib—Vomiting—Methylprednisolone—ankylosing spondylitis	8.33e-06	0.00484	CcSEcCtD
Vismodegib—Rash—Triamcinolone—ankylosing spondylitis	8.27e-06	0.00481	CcSEcCtD
Vismodegib—Dermatitis—Triamcinolone—ankylosing spondylitis	8.27e-06	0.00481	CcSEcCtD
Vismodegib—Rash—Methylprednisolone—ankylosing spondylitis	8.26e-06	0.0048	CcSEcCtD
Vismodegib—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.25e-06	0.0048	CcSEcCtD
Vismodegib—Abdominal pain—Prednisone—ankylosing spondylitis	8.2e-06	0.00477	CcSEcCtD
Vismodegib—Diarrhoea—Betamethasone—ankylosing spondylitis	8.15e-06	0.00474	CcSEcCtD
Vismodegib—Diarrhoea—Dexamethasone—ankylosing spondylitis	8.15e-06	0.00474	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	7.9e-06	0.00459	CcSEcCtD
Vismodegib—Nausea—Triamcinolone—ankylosing spondylitis	7.8e-06	0.00453	CcSEcCtD
Vismodegib—Nausea—Methylprednisolone—ankylosing spondylitis	7.78e-06	0.00452	CcSEcCtD
Vismodegib—Dyspepsia—Methotrexate—ankylosing spondylitis	7.63e-06	0.00444	CcSEcCtD
Vismodegib—Vomiting—Dexamethasone—ankylosing spondylitis	7.57e-06	0.0044	CcSEcCtD
Vismodegib—Vomiting—Betamethasone—ankylosing spondylitis	7.57e-06	0.0044	CcSEcCtD
Vismodegib—Decreased appetite—Methotrexate—ankylosing spondylitis	7.53e-06	0.00438	CcSEcCtD
Vismodegib—Rash—Betamethasone—ankylosing spondylitis	7.51e-06	0.00437	CcSEcCtD
Vismodegib—Rash—Dexamethasone—ankylosing spondylitis	7.51e-06	0.00437	CcSEcCtD
Vismodegib—Dermatitis—Betamethasone—ankylosing spondylitis	7.5e-06	0.00436	CcSEcCtD
Vismodegib—Dermatitis—Dexamethasone—ankylosing spondylitis	7.5e-06	0.00436	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	7.48e-06	0.00435	CcSEcCtD
Vismodegib—Fatigue—Methotrexate—ankylosing spondylitis	7.47e-06	0.00435	CcSEcCtD
Vismodegib—Asthenia—Prednisone—ankylosing spondylitis	7.44e-06	0.00433	CcSEcCtD
Vismodegib—Pain—Methotrexate—ankylosing spondylitis	7.41e-06	0.00431	CcSEcCtD
Vismodegib—Pruritus—Prednisone—ankylosing spondylitis	7.34e-06	0.00427	CcSEcCtD
Vismodegib—Diarrhoea—Prednisone—ankylosing spondylitis	7.1e-06	0.00413	CcSEcCtD
Vismodegib—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	7.09e-06	0.00412	CcSEcCtD
Vismodegib—Nausea—Betamethasone—ankylosing spondylitis	7.07e-06	0.00411	CcSEcCtD
Vismodegib—Nausea—Dexamethasone—ankylosing spondylitis	7.07e-06	0.00411	CcSEcCtD
Vismodegib—Abdominal pain—Methotrexate—ankylosing spondylitis	6.85e-06	0.00399	CcSEcCtD
Vismodegib—Vomiting—Prednisone—ankylosing spondylitis	6.59e-06	0.00384	CcSEcCtD
Vismodegib—Rash—Prednisone—ankylosing spondylitis	6.54e-06	0.0038	CcSEcCtD
Vismodegib—Dermatitis—Prednisone—ankylosing spondylitis	6.53e-06	0.0038	CcSEcCtD
Vismodegib—Asthenia—Methotrexate—ankylosing spondylitis	6.22e-06	0.00362	CcSEcCtD
Vismodegib—Nausea—Prednisone—ankylosing spondylitis	6.16e-06	0.00358	CcSEcCtD
Vismodegib—Pruritus—Methotrexate—ankylosing spondylitis	6.13e-06	0.00357	CcSEcCtD
Vismodegib—Diarrhoea—Methotrexate—ankylosing spondylitis	5.93e-06	0.00345	CcSEcCtD
Vismodegib—Vomiting—Methotrexate—ankylosing spondylitis	5.51e-06	0.00321	CcSEcCtD
Vismodegib—Rash—Methotrexate—ankylosing spondylitis	5.46e-06	0.00318	CcSEcCtD
Vismodegib—Dermatitis—Methotrexate—ankylosing spondylitis	5.46e-06	0.00318	CcSEcCtD
Vismodegib—Nausea—Methotrexate—ankylosing spondylitis	5.15e-06	0.00299	CcSEcCtD
